Cytox Ltd

We are working to find ways to detect diseases early enough to make a difference. Our first challenge; dementia and Alzheimer's disease

Cytox is developing transformational prognostic technology that may contribute to the assessment of an individual's risk of developing dementias such as Alzheimer's disease.

We are collaborating with academic researchers and the pharmaceutical industry to develop blood-based assays to aid in the development of new, more effective dementia treatments.

We intend to play our part in the fight against Alzheimer's disease and other dementias.